LOGIN  |  REGISTER
Astria Therapeutics

Indivior (NASDAQ: INDV) Stock Quote

Last Trade: US$24.48 -0.21 -0.85
Volume: 1,309,427
5-Day Change: 1.37%
YTD Change: 96.94%
Market Cap: US$3.050B

Latest News From Indivior

Rapid induction with SUBLOCADE® showed higher treatment retention rates compared to standard induction, particularly among fentanyl-positive participants RICHMOND, Va. , Oct. 15, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) this week published compelling results from a multicenter, open-label clinical trial published in JAMA Network Open . Two approaches were evaluated for initiating treatment with SUBLOCADE ® ,... Read More
RICHMOND, Va. , Aug. 20, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the following investor events: Morgan Stanley 23 rd Annual Global Healthcare Conference – New York City , NY Joe Ciaffoni , Chief Executive Officer, and Ryan Preblick , Chief Financial Officer, will host 1x1 / group meetings on Monday, September 8 th . Joe Ciaffoni will also participate in a fireside... Read More
Q2'25 Total Net Revenue of $302m ; Q2'25 SUBLOCADE® Net Revenue of $209m , up 9% Year-over-Year Indivior Action Agenda Underway to Strengthen Business and Generate Operational Momentum Conference Call Scheduled for Today at 8:00 A.M. EDT RICHMOND, Va. , July 31, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today reported its financial results for the second quarter ended June 30, 2025, and provided a business update.... Read More
Viking Therapeutics